| Literature DB >> 33778424 |
Yijun Chen1, Peiyu Ye1, Xiaorong Liu2, Chunxiu Gong3, Caifeng Li4, Yue Yuan5, Huyong Zheng6, Xin Xu7, Hongbo Dong1, Qin Kong7, Yinkun Yan1, Jie Mi1.
Abstract
IMPORTANCE: Extensive population-based studies have explored the prevalence of primary hypertension (HTN) in children and adolescents. However, there is little published data on the characteristics of different types of pediatric HTN and the causes of secondary HTN.Entities:
Keywords: Hypertension; Pediatric; Secondary hypertension
Year: 2021 PMID: 33778424 PMCID: PMC7983996 DOI: 10.1002/ped4.12249
Source DB: PubMed Journal: Pediatr Investig ISSN: 2574-2272
Characteristics of included pediatric inpatients with hypertension
| Characteristics | All ( | Primary HTN ( | Secondary HTN ( |
|
|---|---|---|---|---|
| Male | 885 (60.1) | 348 (76.0) | 535 (52.9) | <0.001 |
| Age (years) | ||||
| 0–2 | 94 (6.4) | 0 (0) | 94 (9.3) | <0.001 |
| 3–5 | 163 (11.1) | 2 (0.4) | 161 (15.9) | |
| 6–11 | 592 (40.3) | 156 (34.1) | 436 (43.1) | |
| 12–17 | 621 (42.2) | 300 (65.5) | 321 (31.7) | |
| BMI | 2.3 (0.4, 4.5) | 4.2 (2.7, 5.9) | 0.9 (−0.3, 2.5) | <0.001 |
| SBP | 2.1 (0.9, 3.1) | 2.3 (1.3, 3.1) | 2.0 (0.6, 3.2) | 0.018 |
| DBP | 1.7 (0.5, 3.1) | 1.3 (0.5, 2.5) | 1.9 (0.5, 3.4) | <0.001 |
| Length of stay (days) | 12 (8, 18) | 10 (8, 13) | 14 (9, 22) | <0.001 |
| Readmission | 444 (30.2) | 28 (6.1) | 416 (41.1) | <0.001 |
| Family history of HTN‡ | 383 (36.0) | 288 (65.8) | 95 (15.2) | <0.001 |
Data are shown as n (%) or median (Q1, Q3). †Available for 919 patients. ‡Available for 1065 patients. HTN, hypertension; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure.
FIGURE 1Proportions of primary and secondary hypertension by departments. P < 0.05 for the comparisons of proportion between primary and secondary HTN by departments. †Others including Orthopedics, General Surgery, Dermatology, Neonatology, Otolaryngology, Urology, Gastroenterology, Internal Medicine, Infectious Diseases, Respiratory Medicine, Oral Surgery, and Thoracic Surgery department.
Age and sex distributions among children with primary hypertension according to major comorbidities
| Variables |
All ( | Sex | Age (years)† | |||||
|---|---|---|---|---|---|---|---|---|
|
Male ( |
Female ( |
|
3–5 ( |
6–11 ( |
12–17 ( |
| ||
|
| ||||||||
| Obesity | 347 (75.8) | 264 (75.9) | 83 (75.5) | 0.931 | 1 (50.0) | 126 (80.8) | 220 (73.3) | 0.149 |
| NAFLD | 263 (57.4) | 203 (58.3) | 60 (54.5) | 0.484 | 1 (50.0) | 86 (55.1) | 176 (58.7) | 0.752 |
| Dyslipidemia | 112 (24.5) | 77 (22.1) | 35 (31.8) | 0.039 | 0 (0) | 36 (23.1) | 76 (25.3) | 0.627 |
| Diabetes | 69 (15.1) | 41 (11.8) | 28 (25.5) | 0.001 | 0 (0) | 18 (11.5) | 51 (17.0) | 0.253 |
| OSAS | 69 (15.1) | 55 (15.8) | 14 (12.7) | 0.432 | 1 (50.0) | 24 (15.4) | 44 (14.7) | 0.376 |
|
| 0.395 | 0.194 | ||||||
| 0 | 89 (19.4) | 65 (18.7) | 24 (21.8) | 1 (50.0) | 26 (16.7) | 62 (20.7) | ||
| 1 | 93 (20.3) | 76 (21.8) | 17 (15.5) | 0 (0) | 34 (21.8) | 59 (19.7) | ||
| 2 | 120 (26.2) | 93 (26.7) | 27 (24.5) | 0 (0) | 51 (32.7) | 69 (23.0) | ||
| ≥3 | 156 (34.1) | 114 (32.8) | 42 (38.2) | 1 (50.0) | 45 (28.8) | 110 (36.7) | ||
Data are shown as n (%). †There were no patients with primary HTN in the 0–2 years group, only three age groups were included in the comparisons. NAFLD, non‐alcoholic fatty liver disease; OSAS, obstructive sleep apnea syndrome.
Age and sex distributions of causes of secondary hypertension in pediatric patients
| Causes |
All ( | Sex | Age (years) | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
Male ( |
Female ( |
|
0–2 ( |
3–5 ( |
6–11 ( |
12–17 ( |
| ||
| Renal | 469 (46.3) | 256 (47.9) | 213 (44.7) | 0.309 | 31 (33.0) | 49 (30.4) | 217 (49.8) | 172 (53.6) | <0.001 |
| Rheumatic autoimmune | 205 (20.3) | 85 (15.9) | 120 (25.2) | <0.001 | 11 (11.7) | 44 (27.3) | 88 (20.2) | 62 (19.3) | 0.024 |
| Hematologic and tumor | 93 (9.2)2 | 61 (11.4) | 32 (6.7)2 | 0.010 | 9 (9.6)2 | 29 (18.0) | 37 (8.5)2 | 18 (5.6)2 | <0.001 |
| Cardiovascular | 75 (7.4)2 | 40 (8.4)2 | 35 (6.5)2 | 0.264 | 14 (14.9) | 9 (5.6) | 26 (6.0)2 | 26 (8.1)2 | 0.019 |
| Endocrine | 27 (2.7)2 | 17 (3.2)2 | 10 (2.1)2 | 0.289 | 5 (5.3)2 | 4 (2.5) | 11 (2.5)2 | 7 (2.2)2 | 0.408 |
| Neurologic | 18 (1.8)2 | 13 (2.4)2 | 5 (1.0)2 | 0.098 | 1 (1.1)2 | 2 (1.2) | 7 (1.6)2 | 8 (2.5)2 | 0.671 |
| Others† | 125 (12.4) | 68 (12.7) | 57 (11.9) | 0.714 | 23 (24.5) | 24 (14.9) | 50 (11.5) | 28 (8.7)2 | <0.001 |
Data are shown as n (%). † Others included medications, toxicity and infection.